AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Novo Nordisk (Ozempic)
Acquired
GLP1 Agonist Drugs and Vanta Software
This chapter discusses the promising research on GLP1 agonist drugs, the recent FDA approval of drugs like Ozempic and Ribelsis, and the introduction of Vanta, a software that simplifies security and compliance management.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode